Bristol Myers Squibb and Microsoft Launch Artificial Intelligence Collaboration in Lung Cancer
Bristol Myers Squibb is carrying out a strategic partnership with Microsoft to increase early diagnosis in lung cancer and close treatment gaps.
Bristol Myers Squibb is utilizing artificial intelligence technologies to close gaps in lung cancer care in the United States, accelerate early diagnosis, and identify treatment disparities.
Use of Artificial Intelligence in Lung Cancer
Bristol Myers Squibb is deploying artificial intelligence solutions across the U.S. to address gaps in lung cancer care and increase early detection rates.
Collaboration with Microsoft
The company is using Microsoft's Precision Imaging Network platform to help radiologists analyze X-rays and CT scans and detect hard-to-spot nodules.
In the first phase of this multi-year collaboration, pilot centers such as rural hospitals and community clinics are being included in the process.
American Cancer Society Data
According to American Cancer Society data, lung cancer remains the leading cause of cancer death in the country, with thousands of new cases expected in 2026.